Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sarcoma, Kaposi 1Sarcoma 1Lymphoma 1AIDS-related Kaposi sarcoma 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2tocilizumab 1pembrolizumab 1fialuridine 1entinostat 1Zidovudine 1Valganciclovir 1Therapeutics 1Thalidomide 1SUB1 protein, human 1Rituximab 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Palliative Care 1Nutritional Support 1Nivolumab 1Nelfinavir 1Molecular Diagnostic Techniques 1Immunotherapy 1Etoposide 1Drug Therapy 1Docetaxel 1Diagnostic Tests, Routine 1Celecoxib 1Brentuximab Vedotin 1Biopsy 1Biological Therapy 1Antiretroviral Therapy, Highly Active 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Kaposi × Altretamine × Lymphoid × Clear all
NCT00002936 2013-02-04

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Roswell Park Cancer Institute

Phase 1 Completed
LymphoidSarcoma

AIDS-related Kaposi sarcoma, Lymphoma, Sarcoma, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡